オハイオにおける多発性硬化症の臨床試験
オハイオ内の拠点で、多発性硬化症に関する14件の研究が参加者を募集しています。
オハイオ内の都市
公式研究テキスト（英語）
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- University of Cincinnati Medical Center, Cincinnati
- Riverside Methodist Hospital, Columbus
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/10/01更新 · NCT06782490A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/09/25更新 · NCT07840326A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Cincinnati
- 他4件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/23更新 · NCT06433752Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
被験者募集中第1/2相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT07477639Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- The Ohio State University- Site Number : 8400009, Columbus
- The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
被験者募集中第3相
18歳〜60歳 · 全性別 · 2026/09/15更新 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Cleveland
- TG Therapeutics Investigational Trial Site, Columbus
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06680037An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, Cleveland
被験者募集中第1相
18歳〜60歳 · 全性別 · 2026/08/25更新 · NCT07224373Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis
- Louis Stokes Cleveland VA Medical Center, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/08/17更新 · NCT07768761Understanding and Enhancing Human Health and Movement
- Louis Stokes Cleveland VA Medical Center, Cleveland
被験者募集中
18歳以上 · 全性別 · 2026/07/31更新 · NCT07738978Care in Multiple Sclerosis (MS)
- Cleveland Clinic, Cleveland
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/05更新 · NCT07011914Central Vein Sign in Multiple Sclerosis Extension Study
- Cleveland Clinic Foundation, Cleveland
被験者募集中
18歳〜65歳 · 全性別 · 2026/02/20更新 · NCT07424027Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
被験者募集中
22歳〜75歳 · 全性別 · 2025/09/24更新 · NCT05964829ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。